PreprintCited by 46SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesSARS-CoV-2 detection and testing

Early Computational Detection of Potential High Risk SARS-CoV-2 Variants

Open access
Beguir, Karim, Skwark, Marcin J., Fu, Yunguan, Pierrot, Thomas, Carranza, Nicolas Lopez, Laterre, Alexandre, Kadri, Ibtissem, Korched, Abir +7 more·2021·Computers in Biology and Medicine

Preprint — published as 10.1016/j.compbiomed.2023.106618

Abstract

The ongoing COVID-19 pandemic is leading to the discovery of hundreds of novel SARS-CoV-2 variants on a daily basis. While most variants do not impact the course of the pandemic, some variants pose a significantly increased risk when the acquired mutations allow better evasion of antibody neutralisation in previously infected or vaccinated subjects or increased transmissibility. Early detection of such high risk variants (HRVs) is paramount for the proper management of the pandemic. However, experimental assays to determine immune evasion and transmissibility characteristics of new variants are resource-intensive and time-consuming, potentially leading to delays in appropriate responses by decision makers. Here we present a novel in silico approach combining spike (S) protein structure modelling and large protein transformer language models on S protein sequences to accurately rank SARS-CoV-2 variants for immune escape and fitness potential. These metrics can be combined into an automated Early Warning System (EWS) capable of evaluating new variants in minutes and risk-monitoring variant lineages in near real-time. The system accurately pinpoints the putatively dangerous variants by selecting on average less than 0.3% of the novel variants each week. With only the S protein nucleotide sequence as input, the EWS detects HRVs earlier and with better precision than baseline metrics such as the growth metric (which requires real-world observations) or random sampling. Notably, Omicron BA.1 was flagged by the EWS on the day its sequence was made available. Additionally, our immune escape and fitness metrics were experimentally validated using in vitro pseudovirus-based virus neutralisation test (pVNT) assays and binding assays. The EWS flagged as potentially dangerous all 16 variants (Alpha-Omicron BA.1/2/4/5) designated by the World Health Organisation (WHO) with an average lead time of more than one and a half months ahead of them being designated as such. One-Sentence Summary: A COVID-19 Early Warning System combining structural modelling with machine learning to detect and monitor high risk SARS-CoV-2 variants, identifying all 16 WHO designated variants on average more than one and a half months in advance by selecting on average less than 0.3% of the weekly novel variants.

Integrity signals

Registry

Crossref · 10.1101/2021.12.24.474095

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Beguir, K., Skwark, M. J., Fu, Y., Pierrot, T., Carranza, N. L., Laterre, A., Kadri, I., Korched, A., Lowegard, A. U., Lui, B. G., Sänger, B., Liu, Y., Poran, A., Muik, A., & Sahin, U.
Affiliations
  • BioNTech (Germany) (DE)
  • BioNTech (United States) (US)
Corresponding author
Beguir, Karim
Venue
Computers in Biology and Medicine
Publisher
openRxiv
Published
2021-12-27
Volume
155
Pages
106618-106618
ISSN
0010-4825 (ISSN-L)
OpenAlex
W4319029105
Cited by
46
References
1
Citations by year
2026: 7 · 2025: 7 · 2024: 12 · 2023: 13 · 2022: 7
FWCI
10.35
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Computers in Biology and Medicine (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords
SARS-CoV-2 variants, COVID-19 pandemic, spike protein, immune evasion, antibody neutralization, transmissibility, transformer language models, early warning systems, variants of concern, variants of interest
MeSH terms
COVID-19, SARS-CoV-2, Humans, Mutation, Benchmarking, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review